![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Found 223 studies with search of: | "Ifosfamide" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
A Scandinavian Sarcoma Group Protocol for Patients With High-Risk Soft Tissue Sarcoma of the Extremities and Trunk Wall
|
||||
2 | Recruiting |
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
|
||||
3 | Completed |
A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma
|
||||
4 | Active, not recruiting |
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
|
||||
5 | Completed |
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
|
||||
6 | Recruiting |
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
|
||||
7 | Recruiting |
TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients
|
||||
8 | Recruiting |
Randomised Study Comparing Three Chemotherapy Regimens in Non-Small Cell Lung Cancer
|
||||
9 | Recruiting |
A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant
|
||||
10 | Withdrawn |
Ifosfamide in Treating Patients With Meningeal Tumors
|
||||
11 | Completed |
Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors
|
||||
12 | Completed |
Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
|
||||
13 | Active, not recruiting |
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
|
||||
14 | Recruiting |
Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
|
||||
15 | Active, not recruiting |
Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
|
||||
16 | Recruiting |
Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer
|
||||
17 | Active, not recruiting |
Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma
|
||||
18 | Recruiting |
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
||||
19 | Active, not recruiting |
Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer
|
||||
20 | Recruiting |
Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma
|
![]() |
Previous Page | Studies Shown (1-20) | Next (21-40) |
![]() |